When you evaluate a pharma omnichannel platform, the hard part is rarely finding a system out there. It’s separating hype from impact in a fragmented landscape: most teams are stitching together agencies, media partners, data platforms, CRM workflows, and separate measurement tools. Media is bought by multiple teams and partners. Metrics pass from one partner to another. Change orders appear when the scope shifts. Six-month planning and implementation cycles outlast the decision they were meant to support. Even systems sold as set-and-forget often demand close micromanagement to keep optimization moving.
That makes the standard commercial model worth a closer, more critical look. A no-media-fee SaaS model separates media commissions from platform costs. It can make budget accountability easier as teams are pressured to do more with minimal budget increases, though it may not remove data or internal operating costs. In this guide to pharma omnichannel orchestration, we will look at the commercial details your brand team, finance group, and procurement team should evaluate before choosing a vendor.
The hidden cost of agency-style pharma marketing: How media commissions work
When an agency buys media for a brand, its compensation may be tied to the media budget. The arrangement might be a stated commission, a markup in the media rate, a flat management fee, or a combination of charges. The issue starts when your team cannot see how the fee is calculated, what work it buys, or where it might change throughout your campaign.
Ask four simple questions at the start of a vendor review:
- What amount is each fee based on?
- Does the fee change when media spend changes?
- Which planning, buying, optimization, reporting, and coordination services are included?
- Which work creates a new charge or requires a change order, vs what can be changed without fees and paperwork?
In pharma, an omnichannel program can involve audience strategy, approved content, media activation, field coordination, data connections, measurement, and ongoing optimization. A headline percentage tells your finance team very little if those responsibilities are bundled together. When several partners own different pieces, every handoff creates another place for context, metrics, or accountability to get lost.
Consider a brand launching a focused pilot. The brand lead may have one approved media budget, but the proposal may also include implementation, audience onboarding, data work, and reporting. If those items are mixed into one managed-service fee, the team may struggle to explain what changed when the pilot expands. An itemized scope gives the next budget review a usable starting point.
Budget transparency is also a governance issue. If a provider earns more when media spend rises, ask how channel recommendations are reviewed and how the provider shows that each allocation fits the brand objective. That is a request for visibility into incentives and how new opportunities are evaluated when they fall both within and outside of this partner’s system.
How a SaaS omnichannel platform separates technology and media costs
A SaaS subscription pays for access to software and the capabilities defined in the agreement. Media dollars are the separate budget used to reach selected audiences through paid channels. Implementation, strategic support, data, integrations, creative services, and media buying may sit in other parts of the commercial model.
PharmaForceIQ’s model does not take media commissions, so compensation is not a percentage commission on media it places. The benefit of the structure is visibility and efficiency: your team can easily distinguish technology and partnership costs from the money allocated to placements.
Software alone will not own every responsibility. A platform may support coordinated planning, activation, and measurement. A media partner may handle buying (or they may be the same, as some platform teams can also serve as a media agency of record). A creative partner may develop campaign assets. Your internal teams may own approvals, data access, and governance. Put those responsibilities in writing so no one discovers a missing owner after the pilot starts.
In a fragmented program, the account team can become another handoff. If strategic decisions sit with junior support, channel advice comes from SMEs who are disconnected from strategy, or your team must micromanage a supposedly automated system to keep optimization moving, the plan already carries hidden costs and risks.
When you compare a prospective pharma customer engagement platform, ask what your teams will actually use and what information the system needs. You should be able to explain how it fits with CRM, marketing, and analytics workflows that you are already using, as a system that requires any ‘rip-and-replace’ infrastructure will involve a long and usually slow implementation phase. Our omnichannel approach is designed to augment those capabilities in a matter of weeks rather than force every channel into a new and separate operating model.
In a practical scenario, your brand team wants to move part of an approved budget from an endemic channel into programmatic media during a pilot. Ask who can approve the change, whether the platform records the decision, whether any fee changes with the shift, and how the revised allocation appears in reporting. Do you need to complete a change order and wait on finance teams to agree? A clear answer is needed here, not a broad promise of flexibility.
What a no-media-fee model means for your marketing budget
A no-media-fee model changes how you build and inspect the budget. Create separate lines for platform access, implementation or services, paid media, data and technology dependencies, and internal time. Label each line as fixed, variable, usage-based, one-time, or recurring.
Then ask the vendor to show the assumptions behind each line. How many brands, audiences, channels, markets, and optimization cycles does the proposal cover? What happens when you add another brand? Which data connections are required? Is there a minimum term or media commitment? Do additional users, endpoints, integrations, or reporting requests change the fee?
Imagine your procurement team is onboarding a second brand after the first program establishes a workable process. The first proposal may have included implementation and integration work that should not be charged in the same way twice. Ask for a clear expansion model. You want to know which costs are shared, which costs are brand-specific, and what new work the second brand actually requires.
Separate committed costs from optional costs, and record what is excluded. If a provider assumes that your team will prepare audiences or manage approvals, include that internal effort in the comparison. A lower external fee can still require more work from your brand, analytics, or technology teams.
Compare the models by equivalent scope and operating load. A blended proposal is assessable when the provider supplies the same detail as a separate-fee proposal. Either structure becomes difficult to evaluate when it leaves services, data, ownership, or optimization responsibilities vague.
The next question is operational: once the price is clear, how much work will your team need to keep the program moving?
Compare total cost of ownership: Agency-led buying and SaaS
The labels “agency” and “SaaS platform” do not tell you the full delivery model. Some technology providers offer services with the system, some have add-on consulting services, and some agencies use software in their work. Compare the actual roles, fees, obligations, and handoffs in each proposal. A polished pitch may not work for the messy reality of your team, including multiple partners, repeated status calls, metrics hand-offs, and a long chain of approvals before anyone can act.
| Cost or responsibility | Agency-led buying model | SaaS platform model | Questions for your team |
|---|---|---|---|
| Technology access | May be included in a managed-service fee or provided through a separate tool | Typically defined as platform access in the subscription agreement | Who gets access, what capabilities are included, and what support comes with the subscription? |
| Media budget | Paid placements may be purchased or managed by the agency | Usually budgeted separately from software access | Who controls the budget, approves shifts, and reports the amount reaching placements? |
| Media-related compensation | May include a commission, markup, flat fee, or another arrangement | Can be structured without a media commission, subject to the agreement | What is the calculation base, and do fees change when spend changes? What is excluded from that base? |
| Strategy and services | May be bundled or itemized | May be included, separately scoped, or delivered by another partner | Which deliverables, meeting cadence, optimization work, and response expectations are included? |
| Implementation and integrations | Can be included, separately priced, or handled internally | May require implementation and connections to existing systems | What data mapping, testing, ownership, and one-time charges are required? How long do integrations take to set up? |
| Internal operating effort | Depends on the division of work between client and partner | Depends on team readiness, data, workflow, and governance | How much time will brand, field, analytics, IT, procurement, and MLR teams need? |
Normalize the scope before you compare totals. Match the number of brands, intended audience, channels, geography, campaign duration, services, and measurement expectations. A proposal that excludes data preparation or integration, for example, is not directly comparable with one that includes it.
Next, separate fixed commitments from variable charges. Note the contract term, renewal mechanics, minimum media commitments if any, and the effect of a scope change. Ask for a sample invoice or an illustrative cost breakdown if your finance team needs to understand how charges will appear after launch.
Finally, account for the work required to operate the program. Your brand team may need to supply approved content. Analytics may need to validate measurement. IT may need to support data connections. Field operations may need to review workflow changes. A platform that fits existing systems may reduce handoffs, but your team should test that claim against its own process.
Once you understand the total operating load, move from price comparison to vendor diligence. The most useful questions are the ones that reveal whether the proposed model can work with your data, governance, and decision calendar.
A practical vendor-comparison checklist for pharma MarTech
Bring the following questions to your next vendor meeting. Ask each provider to answer and tie the response to the proposed scope.
Budget control
- Can we see platform, services, data, implementation, and media as separate budget lines?
- Who approves a shift between channels, and how is that decision recorded? What’s the process to do so?
- Do fees change when media spend, brand count, audience size, or channel mix changes?
- Are there minimum commitments, renewal increases, usage thresholds, or termination charges?
Service inclusions
- Which strategy, optimization, buying, reporting, and support activities are included?
- What does our team own, and what does the vendor own?
- Which deliverables have a defined cadence, format, or review process?
- What work requires a change order or a separate partner?
Data readiness and workflow fit
- What data sources, identity rules, permissions, and refresh rates does the program require?
- Who handles mapping, testing, monitoring, and remediation when a source is incomplete or delayed?
- How does the solution fit our CRM, CLM, marketing, analytics, and/or approval workflows?
- Can users see why a recommendation or allocation was made and what action is eligible?
Measurement and decision gates
- Which operating signals can we see early, and which commercial outcomes have a reporting lag?
- Which interactions are deterministic, and which rely on probabilistic or aggregate matching?
- What comparison method, observation period, and baseline will we use?
- What evidence would make us expand, adjust, or stop the pilot?
Keep activity, engagement, behavior change, commercial outcomes, and incrementality separate as you think about system impact. The pharma marketing measurement guide provides a useful framework for that distinction.
If a more intent-led operating model fits your decision, compare the broader program against an optichannel approach. An optichannel approach helps your team choose the channel and message that fit the signal, then use the timing the audience requires, instead of adding more disconnected activity to an already crowded stack.
Frequently asked questions
Does no media fees mean the media itself is free?
No. It means the provider does not charge a media commission under that model. Your brand still funds paid placements and may pay platform, implementation, strategic, data, or other service fees defined in the agreement. But a no-fee model may be more cost effective in the long run considering your overall media spend, technology costs, and current commissions paid.
Can a SaaS platform replace every agency or service partner?
A SaaS platform can support planning, orchestration, activation, and measurement, but it does not automatically replace every service partner. Creative development, regulatory review, media services, data work, and strategic support should each have a clearly assigned owner in the agreement and operating model. Some SaaS partners like PharmaForceIQ can also operate as a media agency of record to help reduce vendor fragmentation.
Is a subscription always cheaper than a commission?
A subscription is not automatically cheaper, but for most pharma marketing budget it can deliver savings. Compare equivalent deliverables and timeframes, including media, subscription, services, implementation, data, and internal effort. Check how fees change when budget, brand count, or scope changes.
What should a vendor disclose about media fees?
Ask whether compensation is a percentage, markup, flat fee, or another arrangement; what amount it is calculated against; and whether it changes with media spend. Also confirm how much reaches placements, who controls buying decisions, and how invoices and performance are reported. Assess how the partner handles minimum audience sizes, mandatory full-list buys, and other costs that can remain ‘hidden’ within the media buying process.
When should a pharma team evaluate a no-media-fee model?
Evaluate it when you are reviewing a new platform, revisiting agency or buying arrangements, planning a pilot, onboarding another brand, or preparing a finance and procurement review. The comparison is strongest when those stakeholders work from the same scope and assumptions.